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Abstract
Mycobacterium tuberculosis strains from 349 patients were isolated in western Sweden during the years 2001–2005. Only 26% of the tuber-
culosis (TB) patients were born in Sweden. All the others were born in any of 42 different countries; 17% in other European countries,
28% in Africa, 16% in Asia, 11% in the Middle East, and 2% in South America. The mean age of the Swedish-born patients was 67 years,
while the mean age among the foreign-born patients was 37 years. The male/female ratio was 1.6 among the Swedes and 0.9 among those
born abroad. Extrapulmonary manifestations of TB were most common among patients born in Africa while lung infections without extra-
pulmonary manifestations were most common in patients born in Europe, including Sweden. Spoligotyping showed that patients with T or
Beijing strains had more pulmonary TB than extrapulmonary TB, while patients with EAI and CAS strains had a high proportion of extra-
pulmonary TB. The ancestral and/or evolutionary older PGG1 strains were more often isolated from the foreign-born patients than from
the Swedish-born patients, who had strains generally being of the evolutionary recent genogroups PGG2/PGG3. We conclude that immi-
gration from countries with a high incidence of TB has a strong impact on the TB epidemiology in western Sweden, a ﬁnding that should
be taken into account by TB control strategists when developing programmes for eradication of TB in low prevalence settings.
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Introduction
Tuberculosis (TB) is a global health problem afﬂicting mainly
the developing part of the world, while many western coun-
tries have a low TB incidence. A larger proportion of TB
among the immigrants originating from countries with a high
incidence of TB characterizes many low-incidence settings.
Recent studies suggest that different clinical manifestations
are linked to geographical origin of the patients [1], as well
as different TB genotypes [2–5].
Sweden is a good example of a low-incidence country
with a TB incidence of 5.5/100 000 [6] and an immigrant
population of about 10% (mostly from high incidence coun-
tries), who accounted for 78% of all TB cases in the year
2007 (http://www.smi.se/statistik/tuberkulos). We therefore
thought it desirable to have a ﬁrst insight concerning the
quantitative distribution of the M. tuberculosis genotypic lin-
eages prevailing among Swedish and foreign-born patients, by
investigating differences concerning demography, clinical man-
ifestations, genotypes, etc., in different patient groups.
Materials and Methods
Patients and bacterial isolates
The study included 349 M. tuberculosis complex clinical isolates
from as many TB patients registered during a 5-year period
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(2001–2005) in Va¨stra Go¨taland and Va¨rmland (mainly Goth-
enburg and surrounding areas) in Sweden. Personal, demo-
graphic and clinical data for the patients were obtained from
mandatory transmission reports and information supplied with
the sample referral. The presence of any extrapulmonary man-
ifestation of TB was recorded as such, including cases with
combined extrapulmonary and pulmonary disease. Cases
recorded as having pulmonary TB were those with no extra-
pulmonary manifestations. Concomitant HIV infection was not
recorded due to Swedish law. The individual patient isolates
were identiﬁed as M. tuberculosis complex by standard micro-
biological procedures in conjunction with one or more molec-
ular tests, such as AccuProbe (Gen-Probe Inc., San Diego, CA,
USA), Cobas Amplicor (Roche Diagnostics Scandinavia AB,
Bromma, Sweden) or GenoType Assay (Hain Lifescience
GmbH, Nehren, Germany). Drug-susceptibility testing to ﬁrst-
line drugs was performed using the Bactec 460TB system (Bec-
ton Dickinson Diagnostic Systems, Sparks, MD, USA) with the
following critical concentrations: streptomycin (1 mg/L), isoni-
azid (0.2 mg/L), rifampin (2 mg/L) and ethambutol (5 mg/L).
Molecular typing
For the extraction of DNA, 1–2 lL of colonies from Loe-
wenstein Jensen medium or 5–10 lL of bacteria in freeze
broth was put into tubes containing 300 lL water. The sus-
pension was heated to 95C for 30 min and then sonicated
in a water bath (Bransonic 2200 Ultrasonic Cleaner, 90W,
47 kHz; Branson Ultrasonic Corp., Danbury, CT, USA). Spol-
igotyping was carried out on the genomic DNA using a
membrane with 43 covalently bound oligonucleotides and
PCR was achieved using primers designated DRa and DRb,
with DRa biotinylated 5¢ to amplify the whole DR region as
described previously [7–9]. Spoligotypes in binary format
were converted to an octal code for comparison with the
SITVIT2 proprietary database of the Pasteur Institute of Gua-
deloupe, which is an updated version of the previously
released SpolDB4 database [10]. At the time of the analyses,
SITVIT2 contained genotyping information on about
65 000 M. tuberculosis clinical isolates from 160 countries of
origin. Major phylogenetic clades were assigned according to
signatures provided in SpolDB4, which deﬁned 62 genetic lin-
eages and sub-lineages for various M. tuberculosis complex
members [10]. Based on the spoligotyping results and clade
deﬁnitions, the isolates typed were also linked to the ances-
tral Principal Genetic Group 1 (PGG1), or evolutionary
younger PGG2/3 groups of M. tuberculosis complex [10–14].
Statistical analysis
Statistical computations with chi-square test, t-test and multi-
ple logistic regression were carried out in R (R Development
Core Team, 2010; http://www.R-project.org). There were a
large number of strata for both origin of the patients and
genotypes in the logistic regression; therefore, the results
from patients born in Europe (including Sweden) and South
America were merged and used as a single reference for ori-
gin, because the patients had similarities in presentation of
the disease and distribution of genotypes. The unclassiﬁed
genotypes and clades with <10 isolates were analysed as a
single group, too.
Results
Origin of the patients
The study included 349 patients from 43 countries (support-
ing Table S1); only 89 (26%) were born in Sweden, while
260 (74%) were foreign-born. Among the foreign-born, the
largest group was from Africa (28% of all patients), followed
by Europe (17%), Asia (16%), the Middle-East (11%) and
South America (2%, Table 2). Among the Africans, 75
patients (21%) were from Somalia.
Age and gender
The age distribution for all patients showed a double peak
(20–40 and 70–90 years). However, when the patients were
divided into Swedish versus foreign-born groups, the age dis-
tribution was not bimodal (Fig. 1a). There was a single peak
for each of the groups; 70–90 years for patients born in
Sweden (mean age 66.6, median 77 years), and 20–40 years
for the foreign-born patients (mean age 37.4, median
34 years; p <0.001). The male/female sex-ratio was 1.6 in the
Swedish patient group and 0.9 for the foreign-born group (p
0.015, results not shown).
Clinical manifestations
A total of 205/349 (59%) of the patients had lung TB with no
signs of extrapulmonary infection, while the remaining 144/
349 (41%) patients had TB with some form of extrapulmonary
manifestations (Table 1). Expressed as the ratio of pulmonary/
extrapulmonary TB (P/E ratio, Table 1), pulmonary TB was
signiﬁcantly more frequent in male patients and Swedish-born
individuals. The P/E ratio for female patients born abroad was
0.9 and for male patients 1.4; for patients born in Sweden the
ratios were 1.8 and 4.0, respectively. Pulmonary TB was also
more common in elderly patients (P/E ratio 1.7 for those
‡65 years). When clinical manifestations of disease were anal-
ysed in relation to origin and age, the P/E ratio among Swedish
patients <65 years was 9.7 vs. 1.1 for foreign born patients
<65 years (p <0.001, Table 1), indicating that the former pop-
ulation was more inclined to develop pulmonary TB.
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Origin of the patients, and clinical and genotyping data
Pulmonary TB was more common among patients originating
in Europe (P/E ratio 2.7), Sweden (P/E ratio 2.9) and South
America (P/E ratio 7.0), though the number of patients from
South America was too low to be conclusive (Table 2,
Fig. 1b). Extrapulmonary manifestations of TB were signiﬁ-
cantly more common in patients born in Africa (P/E ratio
0.7, OR 3.3, p <0.001), underlining an increased risk for
patients of African origin to get extrapulmonary TB. With a
P/E ratio of 1.0 (OR 2.9, p 0.006), extrapulmonary TB was
also more common in patients born in the Middle East than
the reference group, including patients born in Europe
(including Sweden) and South America.
Using genotyping, 313/349 (90%) isolates were classiﬁed
among 10 lineages while 36 (10%) were unclassiﬁed. Six large
lineages (total 297 isolates) are illustrated in Table 2, the
remaining 52 are together designated ‘Other’. Statistical anal-
ysis indicated an increased risk of extrapulmonary TB in
patients infected by the EAI lineage (OR 3.0, p 0.012) and
CAS family (OR 2.4, p 0.047; Table 2, Fig. 1b). In contrast,
lung TB without extrapulmonary manifestations dominated
among the patients infected with the Beijing and T lineages
(adjusted OR of 4.44, 95% CI 1.13–17.54, p 0.033 for pulmo-
nary TB; Table 2).
The proportion of extrapulmonary vs. pulmonary TB in
relation to genotyping data and the geographical origin of the
patients underlined that the distribution of genotypes
observed was dependent on the origin of the patients
(Fig. 1b, Table 3). T clade was most common in patients
born in Sweden (31/89, 35%), Europe (23/59, 39%) and
Africa (29/98, 30%); Haarlem lineage was relatively common
in the Middle East (14/40, 35%) but rare in Africa (5/98, 5%);
EAI was common in Africa (23/98, 23.5%) and Asia (19/55,
34.5%); CAS was equally common in Africa (20/98, 20%) and
Asia (10/55, 18%), and also present to a lesser extent in the
Middle-East (4/40, 10%); Beijing (W) was most commonly
found in Asian-born patients (16/55, 29%).
Certain lineages caused more extrapulmonary TB, while
other lineages dominated in lung TB cases. However, the
multiple logistic regression analysis did not allow any ﬁrm
conclusions regarding whether the genotype or the geo-
graphical origin was the most important factor for the clinical
manifestations, because the number of patients in each group
was too small in most combinations (Table 2). Overall, EAI
and CAS strains caused more extrapulmonary TB (total P/E
ratio 0.5 and 0.6, respectively), but this was nearly solely
traceable to the high proportion of African and Asian-born
patients with extrapulmonary manifestations (EAI:P/E ratio
0.4 for Africa and Asia; CAS:P/E ratio 0.3 for Africa). In con-
trast, the predominance of lung TB without associated extra-
pulmonary manifestations was highest for the Beijing (W)
genotype (total P/E ratio 8.0; nearly solely isolated in Asia-
born patients with a P/E ratio 7.0), followed by the T-family
(total P/E ratio 2.2, mainly isolated from patients born in
Sweden (35% with P/E ratio 2.1), Europe (39%, P/E ratio 4.8)
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FIG. 1. (a) Age distribution of patients born in Sweden and abroad.
(b) Distribution of cases with lung TB (blue bars) and extrapulmo-
nary TB (orange bars). (I) Patients from different geographical areas;
(II) patients infected with different genotypes; (III) selected combina-
tions of geographical origin with associated M. tuberculosis genotype.
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and Africa (30%, P/E 1.4)) and the Haarlem lineage (total P/E
ratio 1.6; mainly found among Sweden-born patients with a
P/E ratio of 4.3).
The isolates were divided into the two principle genetic
groups (PGG). The ancestral or evolutionary older one,
PGG1, contained for example Beijing (W), EIA and CAS, and
the more modern one, PGG2/3, contained for example T, H
and LAM [8,10–13]. A predominance of the more modern
PGG2/3 strains (237/349 or 67.9%) as compared with older
PGG1 strains (112/349 or 32.1%) was found. The P/E ratio
was 0.9 for PGG1 and 1.8 for PGG2/3 strains, suggesting
that irrespective of their speciﬁc genotypic lineage attribu-
tion, taken cumulatively, all PGG1 strains resulted in a higher
proportion of extra-pulmonary disease than PGG2/3 strains
(p 0.003, Table 3), which more often caused lung TB. The
relation between PGG-based classiﬁcation and the geographi-
cal origin of the patients showed that PGG1 strains were
more commonly found among the foreign-born patients
(101/260, 38.9%) than among the Swedish-born patients (11/
89, 12.4%), and this difference was statistically signiﬁcant
(p <0.001). Their predominance in this group was due to
their higher proportion among patients born in Africa and
Asia (89/112 or 79.5% of all PGG1 strains). On the other
hand, the PGG2/3 genogroup was more common among
Swedish-born patients than the foreign-born patients (78/89,
87.6% vs. 159/260, 61.1%).
Drug resistance
A larger proportion of strains from foreign-born compared
with Swedish-born patients were drug resistant. Any drug
resistance was seen in a total of 36/349 (10.3%) strains; 35/
36 of them were found among the 260 foreign-born patients,
as opposed to only 1/89 Swedish-born patients that carried a
drug-resistant strain (p 0.002). Although drug resistance was
seen among practically all genotypes, the largest proportion
of resistant strains was seen among the Beijing strains (7/27,
26%); two of these seven strains were simultaneously resis-
tant to isoniazid, rifampin and ethambutol (one with addi-
tional resistance to streptomycin), and thus classiﬁed as
multidrug resistant (MDR). In total MDR was seen in six
cases: two from Europe, two from the Middle East, one from
Africa and one from Asia (results not shown).
TABLE 2. Multiple logistic regres-
sion analysis predicting extrapul-
monary tuberculosis
Parameters Total (%) PTB (%) EPTB (%) P/E ratio ORa 95% CI p value
Geographical origin
Europe 59 (17) 43 (72.9) 16 (27.1) 2.7 1 NAb NA
South America 8 (2) 7 (87.5) 1 (12.5) 7.0
Sweden 89 (26) 66 (74.2) 23 (25.8) 2.9
Africa 98 (28) 39 (39.8) 59 (60.2) 0.7 3.3 1.79–6.06 <0.001
Asia 55 (16) 30 (54.5) 25 (45.5) 1.2 2.4 1.02–5.50 0.044
Middle-East 40 (11) 20 (50.0) 20 (50.0) 1.0 2.9 1.36–6.08 0.006
Genotypic lineagec
T-family 96 (28) 66 (68.8) 30 (31.3) 2.2 1 NA NA
H 58 (17) 36 (62.1) 22 (37.9) 1.6 1.4 0.69–2.95 0.344
EAI 46 (13) 15 (32.6) 31 (67.4) 0.5 3.0 1.27–6.87 0.012
CAS 36 (10) 13 (36.1) 23 (63.9) 0.6 2.4 1.01–5.72 0.047
LAM 34 (10) 17 (50.0) 17 (50.0) 1.0 2.2 0.95–5.03 0.065
Beijing (W) 27 (8) 24 (88.9) 3 (11.1) 8.0 0.2d 0.06–0.89 0.033
Othere 52 (15) 34 (65.4) 18 (34.6) 1.9 1.4 0.65–2.94 0.393
Data summarize association of geographical origin of the patients and M. tuberculosis complex genotyping data in rela-
tion to pulmonary versus extrapulmonary TB.
PTB, pulmonary TB; EPTB, extrapulmonary TB; P/E ratio, number of PTB/number of EPTB; OR, adjusted odds ratio.
aThe values of 1 in this column represent data used as reference for logistic regression analysis. Note further that
patients born in Europe (including Sweden) and South America under the sub-section geographical origin were
merged as a single reference (see Materials and methods section).
bNA, not applicable because the data are used as reference for logistic regression analysis.
cDetermination of genotypic lineages was based on spoligotyping signatures provided in the SITVIT2 database.
dOR given for extrapulmonary TB, which corresponds to an adjusted OR of 4.44, CI 1.13–17.54, p 0.033 for pulmo-
nary TB.
e‘Other’ includes all smaller sized lineages (<10 strains; S family n = 9, X clade n = 4, BOVIS n = 2, Manu n = 1), and
strains (n = 36) with spoligotyping signatures that are not associated with any well-deﬁned clade in the SITVIT2 data-
base.
TABLE 1. Occurrence of pulmonary versus extrapulmonary
TB in relation to gender, origin and age
Variable Total PTB (%) EPTB (%)
P/E
ratio v2 p value
Gender
Female 172 89 (51.7) 83 (48.3) 1.1 6.85 0.009
Male 177 116 (65.5) 61 (34.5) 1.9
Origin
Foreign born 260 139 (53.5) 121 (46.5) 1.2 11.72 <0.001
Swedish 89 66 (74.2) 23 (25.8) 2.9
Age
<65 years 266 153 (57.5) 113 (42.5) 1.4 0.69 0.407
‡65 years 83 52 (62.7) 31 (37.3) 1.7
Patients <65 years
Female 130 65 (50.0) 65 (50.0) 1.0 5.88 0.015
Male 136 88 (64.7) 48 (35.3) 1.8
Swedish 32 29 (90.6) 3 (9.4) 9.7 16.31 <0.001
Foreign born 234 124 (22.6) 110 (47.0) 1.1
PTB, pulmonary TB; EPTB, extrapulmonary TB; P/E ratio, number of PTB/num-
ber of EPTB.
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Discussion
This study shows that TB epidemiology in western Sweden
is strongly affected by immigration. The patient subpopula-
tions varied signiﬁcantly in age, sex ratio and TB-causing
genotype, as well as clinical manifestation of the disease.
In the present study, nearly three-quarters of the TB
patients were immigrants from more than 40 countries
where the incidence of TB often is very high. For example,
the TB patients from countries in Africa with a high inci-
dence outnumbered the Swedish-born patients; most of
them originated from Somalia. The foreign-born patients
were signiﬁcantly younger than the Swedes, as was also
found previously [6,15]. Immigration from countries with a
high incidence inﬂuences greatly TB epidemiology in Europe
(http://www.eurotb.org/rapports/2005/full_report.pdf). For
example, the crude TB incidence in Sweden is 5.5/100 000,
but varies from 1.2/100 000 among the Swedish-born
patients to 37.5/100 000 among the foreign-born populations
(http://www.smi.se/statistik/tuberkulos), and is estimated to
be as high as 600/100 000 in the Somalis in Sweden. Simi-
larly, a high number of African immigrants in Norway
accounted for most of the imported cases of the disease. As
compared with the total crude TB incidence of 6/100 000 in
Norway, the incidence among patients born in Africa was
211/100 000, and 793/100 000 for patients born in Somalia
[16]. In addition, the origin of the immigrants varies between
different recipient countries, for example in the Netherlands
many TB patients are African-born [1], while in Germany TB
patients more often come from the former Soviet Union
[17]. Immigration from countries with a high incidence may
inhibit the decline or even lead to an increase in incidence in
the recipient country, as seen in the UK, Norway and Swe-
den [18]. Drug resistance as well as clinical manifestations of
disease may also be strongly affected [15]
Interestingly, in our study most Swedish patients were men
(male/female sex-ratio, 1.6), whereas there were slightly more
women among the patients born abroad (M/F 0.9). The latter
result contrasts with those of several international surveys, in
which TB occurs considerably more often in men than in
women [19]. These analyses have, however, generally included
pulmonary TB only, while extrapulmonary TB has not often
been accounted for. In our study, men dominated slightly
among the patients with pulmonary TB who were born abroad
(M/F ratio 1.1), while women had extrapulmonary TB more
often than men. Other studies [1,6,17,20] have also shown
that extrapulmonary TB is more frequent among women,
which may be one of several reasons for sex bias [19].
Regarding geographical origin and clinical manifestations,
pulmonary and extrapulmonary TB were equally common in
patients born in the Middle East and in Asia. Lung TB without
extrapulmonary manifestations was common among European
patients, including those from Sweden and South America,
while extrapulmonary TB was more frequent in African-born
patients (Tables 2 and 3). A similar distribution was seen in a
Dutch study, in which the highest rate of extrapulmonary TB
(59%) was seen among the Somali patients [1]. In a German
study, extrapulmonary TB was nearly equally distributed
among African and Asian patients [17]. We further investi-
gated the strain genotypes, and observed that EAI and CAS
strains caused more extrapulmonary TB, essentially due to a
TABLE 3. Proportion of extrapulmonary versus pulmonary TB in relation to the M. tuberculosis complex genotypic lineages,
PGG based classiﬁcation of strains, and the geographical origin of the patients
Genotypic
characterization
Sweden Europe South America Africa Asia Middle-East TOTAL
PTB EPTB
P/E
ratio PTB EPTB
P/E
ratio PTB EPTB
P/E
ratio PTB EPTB
P/E
ratio PTB EPTB
P/E
ratio PTB EPTB
P/E
ratio PTB EPTB
P/E
ratio
Genotypic lineagea
T 21 10 2.1 19 4 4.8 2 0 – 17 12 1.4 3 0 – 4 4 1.0 66 30 2.2
H 13 3 4.3 10 6 1.7 1 0 – 2 3 0.7 3 3 1.0 7 7 1.0 36 22 1.6
EAI 2 1 2.0 0 0 – 0 0 – 7 16 0.4 5 14 0.4 1 0 – 15 31 0.5
LAM 6 2 3.0 3 3 1.0 3 1 3.0 4 8 0.5 0 1 – 1 2 0.5 17 17 1.0
CAS 1 1 1.0 0 0 – 0 0 – 5 15 0.3 5 5 1.0 2 2 1.0 13 23 0.6
Beijing (W) 4 0 – 3 0 – 0 0 – 0 1 – 14 2 7.0 3 0 – 24 3 8.0
Otherb 19 6 3.2 8 3 2.7 1 0 – 4 4 1.0 0 0 – 2 5 0.4 34 18 1.9
Total 66 23 2.9 43 16 2.7 7 1 7.0 39 59 0.7 30 25 1.2 20 20 1.0 205 144 1.4
Principal genetic groupc
PGG1 7 4 1.8 3 0 – 0 0 – 12 32 0.4 24 21 1.1 7 2 3.5 53 59 0.9
PGG2/3 59 19 3.1 40 16 2.5 7 1 7.0 27 27 1.0 6 4 1.5 13 18 0.7 152 85 1.8d
PTB, pulmonary TB; EPTB, extrapulmonary TB; P/E ratio, number of PTB/number of EPTB.
aDetermination of genotypic lineages was based on spoligotyping signatures provided in the SITVIT2 database.
b‘‘Other’’ includes all smaller sized lineages (<10 strains; S family n = 9, X clade n = 4, BOVIS n = 2, Manu n = 1), and strains (n = 36) with spoligotyping signatures that are
not associated with any well-deﬁned clade in the SITVIT2 database.
cClassiﬁcation of isolates under principal genetic groups (PGG) was used to discriminate evolutionary modern strains (PGG 2/3) from evolutionary ancient strains (PGG1).
dThe difference in numbers for pulmonary/extrapulmonary tuberculosis in PGG1 versus PGG2 was statistically signiﬁcant (v2 = 8.87, p 0.003).
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high proportion of Africa and Asia-born patients with extrapul-
monary manifestations, whereas Beijing (W) genotype strains
among Asian patients essentially resulted in lung TB without
associated extrapulmonary manifestations. A statistically signif-
icant link between infecting genotypes and the type of the dis-
ease was observed for EAI (p 0.012) and Beijing (p 0.033). The
high proportion of extrapulmonary TB for the EAI and CAS
lineages could be alternatively explained by the prevalence of
the different clades in different population groups, thus reﬂect-
ing dispositions of the patients to develop extrapulmonary
symptoms. Nonetheless, the fact that T-family strains generally
resulted in lung TB in African patients and not extrapulmonary
TB, suggests that the origin of the patient and the infecting
genotype are equally important factors inﬂuencing the mani-
festation of the disease. These observations corroborate a
recent study showing a positive association of CAS and
M. bovis lineage strains with extrapulmonary disease [5]. Our
results further underline that irrespective of their speciﬁc
genotypic lineage attribution all PGG1 strains resulted in a
higher proportion of extrapulmonary disease than PGG2/3
strains (Table 3). Interestingly, PGG1 strains were more com-
monly found among the foreign-born patients than the Swed-
ish patients, an observation that reﬂected the higher
proportion of ancestral M. tuberculosis genotypes in Africa and
Asia [10,11].
The present investigation showed that immigration has a
very strong impact on the TB epidemiology in Sweden. Fur-
thermore, drug resistance was more common among the
strains isolated from foreign-born than from Swedish-born
patients; all MDR cases were limited to the foreign-born
group. Our ﬁndings further underline the link between the
geographical origin of the patient, clinical manifestations of
tuberculosis, and the genotype of the strain. We conclude
that immigration from countries with a high incidence of TB
has a strong impact on the TB epidemiology in western Swe-
den, and TB control strategists, when developing pro-
grammes for eradication of TB in low-prevalence settings,
should take these ﬁndings into account.
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